Moreover, TCTP mRNA levels were significantly upregulated in ovarian cancer (OC) organoids generated from pluripotent stem cells (iPSC) of patients bearing the germline pathogenic breast cancer susceptibility gene 1 (BRCA1) mutation[37]. The gene discussed is TPT1; the disease is ovarian carcinoma.